- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
16 Cards in this Set
- Front
- Back
|
Short term effects of diabetes
|
Polyuria, polydypsia, polyphagia
|
|
Long term effects of diabetes
|
1- Cardiovascular dysfunctions: compromised circulation, inc atherosclerosis, renal damage (diabetic nephropathy)
2- Vision changes: diabetic retinopathy (macular edema), altered osmotic pressure in lens, glaucoma, cataracts 3- Peripheral neuropathy 4- Inc infections |
|
T/F Diabetic pathologies can be reduced if blood glucose regulation is maintained
|
True
|
|
Protamine insulin
|
Insulin + protamine= larger crystals and longer duration of action
* Genetically engineered human insulins are now used |
|
Short acting insulins (2-5 hrs) (4)
|
1- Crystalline insulin
2- Lispro 3- Aspart 4- Glulisine |
|
Long acting insulins (24+ hrs) (2)
|
1- Detemir
2- Glargine |
|
Intermediate acting insulin
|
1- Isophane (NPH) insulin
- Neutral protamine Hagedron - Insulin + protamine - Most likely to be antigenic |
|
1st generation of sulphonylureas (3)
|
1- Tolbutamide
2- Tolazamide 3- Chlopropamide |
|
2nd generation of sulphonylureas (3)
|
1- Glipizide
2- Glyburide 3- Glimepiride |
|
Sulphonylurea-like agents (2)
|
1- Repaglinide
2- Nateglinide |
|
Stimulators of insulin release overview
|
- The sulphonylureas and sulphonylurea-like agents
- Bind to a site on K+ channels and inhibit K+ movement - Toxicities: hypoglycemia and hypoglycemic shock - Indications: Type 2 diabetic changes; Px when diet isn't enough - Contraindications: Renal & hepatic dysfunctions |
|
Incretin analogs (2)
|
1- Exenatide: Activates receptor (increase insulin); SE pancreatitis
2- Liraglutide: Activates a receptor |
|
DPP-4 Inhibitors (3)- Anti-hyperglycemic
"the Gliptins" |
1- Sitagliptin
2- Saxagliptin 3- Linagliptin |
|
Insulin Enhancers (3)
|
1- Metformin: DOC for type 2 diabetics; enzyme activator; inc glucose absorption by muscle and dec its production in the liver; SE. lactic acidosis (potentially fatal), nausea, and diarrhea
2- Rosiglitazone: Binds to PPAR receptor; SE: weight gain, edema, macular edema, inc CHF 3- Pioglitazone: " " |
|
Alpha-glucosidase inhibitors (2)
|
1- Acarbose
2- Miglitol - Anti-diabetic drugs - SE: cramps, diarrhea |
|
Amylin analog (1)
|
1- Pramlintide
- Binds to a receptor; dec gastric emptying and appetite - SE: hypoglycemia |